屈健 |
2012级博士 |
1. Jian Qu，Ying Zhang, Zhi-Quan Yang, Xiao-Yuan Mao, Bo-Ting Zhou, Ji-Ye Yin, Hui He, Xiang-Ping Li, Hong-Yu Long, Nan Lv, Xiao-Jing Xu, Bo Xiao, Yu Zhang, Qiang Tang, Dong-Li Hu, Hong-Hao Zhou& Zhao-Qian Liu. Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population. CNS Neuroscience & Therapeutics. 2014 Feb;20(2):140-6. (IF=4.443, 国际重要期刊) .
2. He Z, Qu J, Zhang Y, Mao C, Wang Z, Mao X, Deng Z, Zhou B, Yin J, Long H, Xiao B, Zhang Y, Zhou H, Liu Z. PRRT2 Mutations Are Related to Febrile Seizures in Epileptic Patients. Int J Mol Sci. 2014 Dec 16;15(12):23408-23417. (IF=2.339, 并列第一, 国际重要期刊).
3. Qu Jian，Yang ZQ, Zhang Y, Mao CX, Wang Z, Mao X, Deng Z, Zhou B, Yin J, Long H, Xiao B, Zhang Y, Zhou H, Liu Z. Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies. Journal of the Neurological Sciences.(IF=2.262, Accepted,并列第一, 国际重要期刊).
4. Hong Sun,Qiang Qu, Jian Qu, Xiao-Ya Lou,Yan Peng,Ying Zeng, Guo Wang.URAT1 Gene Polymorphisms Influence Uricosuric Action of Losartan in patients with hypertension and hyperuricemia. Pharmacogenoics .(IF= 3.425, Accepted, 并列第一, 国际权威期刊). |
刘荣 |
2013级博士 |
1.Liu R, Guo CX, Zhou HH. Network-based approach to identify prognosticbiomarkers for estrogen receptor–positive breastcancer treatment with tamoxifen. Cancer Biology & Therapy 2015. 16(2):317-324 (IF=3.63, 国际重要期刊)
2. Liu R, Cheng Y, Yu J, Lv QL, Zhou HH. Identification and validation of gene module associated with lung cancerthrough coexpression network analysis. Gene. 2015.563(1):56-62. (IF=2.08)
3. Li X, Liu R, Luo ZY, Yan H, Huang WH, Yin JY, Mao XY, Chen XP, Liu ZQ, Zhou HH, Zhang W. Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients. Pharmacogenomics. 2015 Apr 15:1-8. (IF=3.43, 并列第一, 国际权威期刊)
4. Li X, Liu R, Yan H, Tang J, Yin JY, Mao XY, Yang F, Luo ZY, Tan SL, He H, Chen XP, Liu ZQ, Li Z, Zhou HH，Zhang W. Effect of CYP2C9-VKORC1 interaction on warfarin stable dosage and its predictive algorithm. The Journal of Clinical Pharmacology, 2015. 55(3): 251–257. (IF=2.47, 并列第一, 国际重要期刊)
5.Liu R, Lv QL, Yu J, Hu L, Zhang LH, Cheng Y, Zhou HH. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 2015. Doi:10.1007/s10549-015-3428-x (IF=4.20, 国际权威期刊) |
李慕鹏 |
2013级博士 |
1．Li MP, Tang J, Wen ZP, Zhang YJ, Zhang W, Zhou HH, Zhang Z, Chen XP*. Influence of P2Y12 polymorphisms on platelet activity but not ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects. Blood Coagul Fibrinolysis [Accepted 2015 Feb 24] (IF=1.38)
2. Li MP, Tang J, Zhang ZL, Chen XP. Induction of both P-glycoprotein and specific cytochrome P450 by aspirin eventually does not alter the antithrombotic effect of clopidogrel. Clin Pharmacol Ther.2015 Apr; 97(4):324. (IF=7.390 国际权威期刊)
3. Li MP, Xiong Y, Xu A, Zhou JP, Tang J, Zhang ZL, Zhou HH, Zhang W, Chen XP. Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects. Int J Hematol. 2014 Mar;99(3):263-71. (IF=1.679)
4. 李慕鹏，熊艳，陈小平。抗血小板药物替格瑞洛药代药效动力学及遗传药理学研究进展。中国临床药理学与治疗学。2014, 19(2):214-222 |
